A Win For Gamida Cell Ltd.

Fri, Jan 19, 2024 at 07:20 PM
A Win For Gamida Cell Ltd.

Gamida Cell Ltd. (GMDA:NASDAQ) jumped higher at $0.3, representing a gain of 27%. The stock got featured on our News Catalysts scanner on Wed, Jan 17, 2024 at 10:28 AM in the 'MISCELLANEOUS' category. From Fri, Jan 05, 2024, the stock recorded 11.11% Up Days and 20.00% Green Days

The stock spiked on Fri, Dec 29, 2023 at $0.48 with a volume of 6M+.

About Gamida Cell Ltd. (GMDA:NASDAQ)

Gamida Cell Ltd is engaged in the development of cellular and immune therapeutics for cancer and rare genetic diseases. The company's lead product candidate is NiCord, a nicotinamide (NAM)-expanded cord blood cell therapy for use as a curative stem cell graft for patients in hematopoietic stem cell transplant. It is also developing NAM-NK, an innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.